Ask AI
BREAKWATER
BREAKWATER: PFS From the Phase III Trial of 1L Encorafenib + Cetuximab + Chemotherapy vs SoC for BRAF V600E–Mutant mCRC

Released: June 04, 2025

Expiration: December 03, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 04, 2025

Expiration: December 03, 2025